CTNM
CTNM

Contineum Therapeutics Inc-A

NASDAQ · Pharmaceuticals
$15.00
+0.52 (+3.59%)
Analyst Consensus
Strong Buy
13 analysts
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +158.8% upside
Low Target $27.95
Average Target $38.82
High Target $46.43
Current Price $15.00
Current
$15.00
Target
$38.82
$27.95 $38.82 avg $46.43